A Drosophila model of Fragile X syndrome exhibits defects in phagocytosis by innate immune cells

Fragile X syndrome, the most common known monogenic cause of autism, results from the loss of FMR1, a conserved, ubiquitously expressed RNA-binding protein. Recent evidence suggests that Fragile X syndrome and other types of autism are associated with immune system defects. We found that mutants exh...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of cell biology Vol. 216; no. 3; pp. 595 - 605
Main Authors O'Connor, Reed M, Stone, Elizabeth F, Wayne, Charlotte R, Marcinkevicius, Emily V, Ulgherait, Matt, Delventhal, Rebecca, Pantalia, Meghan M, Hill, Vanessa M, Zhou, Clarice G, McAllister, Sophie, Chen, Anna, Ziegenfuss, Jennifer S, Grueber, Wesley B, Canman, Julie C, Shirasu-Hiza, Mimi M
Format Journal Article
LanguageEnglish
Published United States Rockefeller University Press 06.03.2017
The Rockefeller University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Fragile X syndrome, the most common known monogenic cause of autism, results from the loss of FMR1, a conserved, ubiquitously expressed RNA-binding protein. Recent evidence suggests that Fragile X syndrome and other types of autism are associated with immune system defects. We found that mutants exhibit increased sensitivity to bacterial infection and decreased phagocytosis of bacteria by systemic immune cells. Using tissue-specific RNAi-mediated knockdown, we showed that Fmr1 plays a cell-autonomous role in the phagocytosis of bacteria. mutants also exhibit delays in two processes that require phagocytosis by glial cells, the immune cells in the brain: neuronal clearance after injury in adults and the development of the mushroom body, a brain structure required for learning and memory. Delayed neuronal clearance is associated with reduced recruitment of activated glia to the site of injury. These results suggest a previously unrecognized role for Fmr1 in regulating the activation of phagocytic immune cells both in the body and the brain.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
R.M. O’Connor and E.F. Stone contributed equally to this paper.
ISSN:0021-9525
1540-8140
DOI:10.1083/jcb.201607093